Parenteral nutrition is a well-established technique for feeding patients with intestinal failure and other conditions which render enteral feeding impossible. Biochemical tests are required in the initial assessment of these patients, for monitoring their response to treatment and for the detection and management of complications. The use of these tests is discussed critically and guidelines are provided for the frequency with which they should be performed. Chemical pathologists and clinical biochemists have an important role in the provision of parenteral nutrition as members of multi-disciplinary nutrition teams.
Parenteral (intravenous) nutrition is required when it is impossible to provide a patient's nutritional requirements enterally, either by mouth. or through a tube into the stomach or small intestine. Indications include intestinal failure. pancreatic and high intestinal fistulae. and hypercatabolic states (such as severe sepsis and multiple trauma) when nutritional requirements may be greatly increased. Most District General Hospitals should be able to provide parenteral nutrition for adult patients and occasionally for children. This article reviews the role of the clinical chemistry laboratory in the initial assessment of these patients and in monitoring their response to treatment. We also review the metabolic complications of parenteral nutrition. with a view to the central role the laboratory has in their diagnosis and management.
The parenteral nutrition of neonates involves additional special factors which are not relevant in adults. I These include physiological immaturity. additional nutritional requirements and small sample size. Because of its highly This paper was prepared at the invuuuon of the Clinical Laboratory lnvcstigution Working Party of the Scicntific Committee of the Association of Clinical Biochemists. hut does not necessarily reflect their views. specialised nature. neonatal parenteral nutrition is excluded from this review.
Initial assessment
The decision to provide nutritional support for a patient should be based either on evidence of an existing nutritional deficiency, or on the potential risk of developing such a deficiency. Although clinical features related to specific nutrients may be prominent. patients requiring parenteral support usually have. or are at risk of developing. generalised protein-calorie malnutrition.
Anthropometric abnormalities of generalised malnutrition include weight loss and decreases in skinfold thickness, mid-arm muscle circumference and grip strength.?: 3 Biochemical abnormalities include hypoproteinaemia, decreased urinary creatinine excretion and decreased urinary 3-methylhistidine excretion. Anaemia and a low peripheral blood lymphocyte count are also commonly present. The detection of these abnormalities is, however. not necessarily of value in the management of individual patients. Biochemical tests can also provide evidence of the existence and extent of specific nutritional deficiencies. and indicate the presence of other metabolic abnormalities. Such abnormalities may require correction before nutritional support is provided or may impose limitations on the nutritional regimen that can be prescribed.
Biochemical tests ror generalised malnutrition

PLASMA PROTEINS
The plasma proteins that have been most widely used in the diagnosis of malnutrition are albumin and transferrin. Unfortunately. there are many causes of a low plasma concentration of both these proteins and it is often impossible to separate the contributions of nutrient deficiencies from those of the underlying disease (e.g, liver disease. protein-losing entero~athy).
While changes in the rates of synthesis and catabolism of albumin undoubtedly contribute to the hypoalbuminaemia that is common in the very ill. a redistribution of albumin between the intra-and extravascular spaces can have a profound effect on its plasma concentration.t" Similar considerations apply to transferrin." the plasma concentration of which is also affected by iron status and the acute phase response. Decreased serum concentrations of retinolbinding protein and prealbumin are characteristi.c of generalised malnutrition and are m~)fe. sens~· tive than either transferrin or albumm m this respect. 7 In spite of this greater sensitiv.ity t~e.y have not been shown to be useful in the Identification of patients requiring nutritional support.
URINARY CREATININE EXCRETION
Creatinine is a product of normal muscle metabolism and the urinary excretion of creatinine correlates well with muscle mass. The 24-h excretion can be related to reference values for healthy people of the same height (creatinineheight indexj.'"!' a value of <SO'Yo is taken as abnormal while <SO'Yo indicates gross muscle wasting. although this is usually obvious clinically. There are two major factors which adversely affect the reliability of this index: they are the problem of obtaining an acc~rately timed 24-h urine collection and the innate variability of urinary creatinine excretion. for which the standard deviation may be as much as 25% of the mean.'? In addition. urinary creatinine excretion declines with age, even with normal renal function.
URINARY 3-METHYI.HISTIIHNE EXCRETION
This amino acid is a unique product of muscle protein breakdown. and is not re-utilised in the body. Its urinary excretion provides a measure of muscle catabolism. but is dependent upon muscle mass as well as turnoverY Thus. excretion could be increased by greatly accelerated catabolism in a patient with a small muscle mass. or a lesser degree of catabolism in a patient with a normal muscle mass. The measurement of 3-methylhistidine is technically demanding and despite promising early results. it has not found favour as an index of nutritional status. 14 
TilE VALUE OF TESTS IN THE DIAGNOSIS
OF GENERALISED MALNUTRITION
When parenteral nutrition was a less widely available technique for providing nutritional support. considerable reliance was placed upon biochemical and other objective tests of nutritional status to identify those patients in whom it should be used. J. II. 1:1. If, It is now more usual to rely primarily on clinical assessment. Clinical history-taking and examination has been shown to be a valid and reproducible technique for nutritional assessment.'? In a recent study of 59 surgical patients who were assessed for evidence of malnutrition. clinical assessment was shown to be more superior. both in terms of specificity and sensitivity. in predicting the development of infection. a malnutrition-related complication than various objective tests.!" The objective tests used included serum albumin. serum transferrin. creatinine-height index and two non-biochemical tests. delayed cutaneous hypersensitivity and percentage of body fat. Even when the results of the objective tests were combined to produce a 'prognostic nutritional index'. the specificity was not as good as that of subjective assessment. although the sensitivity was similar. The single best objective test was the creati~ine height index. Although the number of patle~ts in this study was too small to be conclusive and only one complication of malnutrition was used as an index. it does suggest that laboratory tests are not required to diagnose malnutrition.
Biochemical tests ror specific nutrient deficiency
MINERAl.s Deficiencies of major minerals may readily be detected by routine biochemical testing. Trace minerals are often provided in standard amounts in nutritional regimens and the presence of pre-existing deficiencies. for example of magnesium and zinc. should be sought by taking a blood sample for measurement of the plasma concentrations before embarking on intravenous replacement; this will. indicate whether additional amounts need to be provided. Iron deficiency can be detected by measurements of haemoglobin and red cell indices. Although these may also be affected by the underlying disease process. more formal assessment of iron status" is. in practice. rarely necessary.
VITAMINS
There is no need to attempt to define watersoluble vitamin status before starting parenteral nutrition. A standard 'cocktail' of water-soluble vitamins is usually prescribed which should contain amounts (especially of folic acid and thiaminc r" comfortably exceeding the minimum recommended intakes. Water-soluble vitamins arc relatively non-toxic and the cost of any excess will be minimal in comparison with the cost of formally assessing an individual patient's requirements, It is rarely necessary directly to assess fat-soluble vitamin status. A prolongation of the prothrombin time provides indirect evidence of vitamin K status. although it can also be prolonged as a result of hepatobiliary disease. The serum calcium and phosphate concentrations and alkaline phosphatase activity provides indirect but non-specific evidence of vitamin D status. The liver stores considerable quantities of vitamin A; although vitamin A deficiency can occur in patients with generalised malnutrition. it may be related to decreased release from the liver rather than to defective storage or absorption of the vitamin." Vitamin E deficiency is very rare in adults although premature infants arc at risk of developing deficiency. With the exception of vitamin D. it is safe to prescribe fat-soluble vitamins on an empirical basis in amounts considered normal for patients being fed enterally. Vitamin D. even when given in normal amounts, can cause hypcrcatcucmiu.F as discussed in a later section.
Biochemical tests for concurrent disease
Before a nutritional regimen is prescribed. knowledge of the patient's fluid and electrolyte status. and renal and hepatic function will identify constraining factors (for example. renal failure necessitating fluid restriction) and any major metabolic imbalances which should be corrected first.
If not already performed. measurements of serum/plasma sodium. potassium. total CO 2 • Parenteral nutrition 329 urea. creatinine, glucose. calcium. phosphate. magnesium. zinc. bilirubin. aspartate aminotransferase and alkaline phosphatase are necessary before starting parenteral nutrition. Urine sodium. potassium and urea excretion may also provide useful information.
Monitoring
Monitoring during parenteral nutrition is necessary to assess the response of patients to treatment and to detect complications. The metabolic complications of parenteral nutrition have recently been comprehensively reviewed.P In general, biochemical monitoring needs to be more intensive in the first few days of parenteral nutrition. when requirements may be changing rapidly and when laboratory tests will often be required for the management of the underlying disease. In practice. many factors dictate what tests are performed and their frequency. It is therefore inappropriate to make rigid recommendations about the frequency of biochemical testing during parenteral nutrition. We will comment critically on the measurement that are used. emphasise those of particular importance and suggest a minimum frequency for their being made (Table) .
SODIUM AND POTASSIUM
The plasma or serum sodium concentration is one of the most frequently measured biochemical variables in clinical medicine. but its interpretation is rarely straightforward. It is essential that the significance of the serum sodium concentration is evaluated in the light of the clinical circumstances. A normal value does not necessarily imply normal sodium status.
Ilypernatraemia reflects a deficit of water in relation to the amount of sodium present; it may be due to an excess of sodium. but more frequently there is actually a deficit of sodium as well as water. Causes of a water deficit during parenteral nutrition include a urea-or glucose-induced osmotic diuresis. while the administration of sodium-containing antibiotics. plasma expanders and drugs dissolved in saline can produce hypernatraemia due to sodium overload.
Hyponatraemia is a common finding in patients receiving parenteral nutrition. but is often mild (125-135 mmol/L) and of little clinical significance. It is frequently multifactorial, 2~. 25 It is more often related to water overload. with or without concomitant sodium depletion. than to sodium depletion alone. It must be emphasised that these arc the minimum frequencies for thc various tests. The clinical circumstances may dictate a greater frequency for individual patients (see text). All the tests indicated. with the exception of those on urine. should in addition be made before parenteral nutrition is started.
Rapid changes in glucose concentration can also contribute to hyponatraemia. Potassium requirements during parenteral nutrition are very variable.2.1 The catabolic patient is often hyperkalaemic and must be potassium-restricted. but in anabolic patients and in patients on an insulin infusion to control hyperglycaemia, there is a rapid transfer of potassium from the extracellular to the intracellular compartment and daily requirements may exceed 11K) mmol. Because of the adverse effects of both hypo-and hyperkalaemia. close monitoring of the serum potassium is essential. For the first week of parenteral nutrition. or until the serum potassium concentration is stable. it should be measured daily. Occasionally. more frequent measurements are needed. Once a patient is in a stable clinical and metabolic condition. alternate daily measurements are usually sufficient. but in some patients. for example those with renal impairment. daily measurements should be continued.
The 24-h urinary excretion of sodium can provide useful information if accurate collcc-tions can be made. but. like the serum concerttrations, is open to misinterpretation. If renal function is normal. sodium depletion should lead to renal sodium retention. but patients who arc stressed (e .g.. septic. post-operative) usually retain sodium irrespective of their sodium status. The natriuresis that follows il period of stress-induced sodium retention is not an indication for equivalent sodium replacement. Indeed. only during the diuretic phase 01" acute renal failure is it usually appropriate to attempt to replace urinary losses of sodium (and potassium). Urinary sodium excretion may be inappropriately high both in a sodiumdepicted patient. whose extracellular fluid volume is being maintained by continuous intravenous fluid administration. and in patients with the syndrome 01" inappropriate antidiuresis. but a low sodium excretion in an unstressed patient docs suggest sodium depiction. A low urinary potassium excretion may indicate the need for additional potassium replacement. Twenty-four hour urine collections are often made for the measurement of urea excretion in order to assess nitrogen balance; twice-weekly collections are usually adequate for this purpose but in patients who are metabolically unstable. it may be helpful to assess urinary sodium and potassium excretion more frequently.
SERUM TOTAl. C02
The serum total CO 2 is useful as a crude indicator of acid-base status but if any doubt exists as to the significance of <to abnormal concentration. a direct measurement of arterial hydrogen ion concentration should be made. This will be necessary anyway in patients who are being ventilated. With the virtual abandonment of energy substrates other than glucose and lipid emulsions. non-respiratory acidosis is now an uncommon complication of parenteral nutrition itself. although it may be present incidentally. e.g. because of renal failureY Respiratory acidosis, due to excessive carbon dioxide production. is an occasional hazard if glucose is provided in excess of requirements. particularly in patients with respiratory insufficiency. Loss of gastric secretions by aspiration. or of intestinal. pancreatic or biliary secretions through a fistula. may also compromise acidbase homeostasis. Total CO 2 is frequently measured as part of an 'electrolyte' profile but while daily measurements are desirable in unstable patients on parenteral feeding. and those with fistulae, renal impairment, etc.. they are not necessary in the more stable patient. We recommend a minimum frequency for total CO 2 measurements of twice weekly after the first week of parenteral nutrition.
SERUM UREA ANI> CREATININE
The serum creatinine concentration is a more reliable guide to renal function than the serum urea. However. serum creatinine may appear normal in a severely wasted patient with significant renal impairment. while as muscle bulk increases with nutritional support. so too does creatinine production. In practice. however. such changes are rarely clinically misleading.
The serum urea reflects urea synthesis from amino acids as well as renal function. An increase in urea concentration in a patient whose serum creatinine is unchanging and who is not oliguric suggests either excessive endogenous protein breakdown or the provision of amino acids in excess of the body's ability to utilise them. The serum urea and creatinine should be measured daily for the first 1-2 weeks of parenteral feeding; thereafter. twice-weekly
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measurements are sufficient. unless clinical considerations dictate otherwise.
GI.UCOSE
Although glucose is usually well tolerated as an energy substrate. hyperglycaemia may occur in patients receiving total parenteral nutrition. particularly if they are stressed. diabetic. or being treated with corticosteroids. Episodes of hyperglycaemia were reported to have occurred in 47 out of 100 consecutive patients treated with parenteral nutrition in one series.i" and our own experience suggests that this is not an unusually high figure. Hyperglycaemia should be avoided as it leads to an osmotic diuresis and dehydration. and indicates that glucose is being under-utilised. Patients who become glucoseintolerant require insulin. and it may also be appropriate to increase the proportion of energy supplied in the form of lipid. Frequent monitoring of glucose status is therefore essential during parenteral nutrition. We recommend 6-hourly urine testing for glucose as a routine during the first few days of parenteral feeding. backed up by blood glucose determinations if there is more than a trace of glycosuria. If reagent strips are used for blood measurements. it is essential that staff are adequately trained in their use. When patients are metabolically stable. the blood glucose need only be measured daily. However. routine testing of the urine twice daily is a simple procedure and the presence of glycosuria in a hitherto stable patient can be a useful early sign of insulin resistance due to sepsis. Minor degrees of glucose intolerance can be overcome by adding insulin directly to the feed but in more severe hyperglcyaemia, insulin is best given as a separate infusion and 4 to 6-hourly measurements of blood glucose will then be required to determine the dose.
Hypoglycaemia is uncommon during parenteral nutrition unless large amounts of insulin are being given; performing peritoneal dialysis may precifitate hypolycaemia under these conditions.? Patients are at risk of hypoglycaemia if parenteral feeding is stopped suddenly. If it is ever necessary to do this (e.g.• because of fluid overload). it is essential to monitor the blood glucose concentrations for the next 12 h.
SERUM PHOSPHATE
Patients given parenteral nutrition. particularly if they are already malnourished. have high phosphate requlrements-': 211 as a consequence of intracellular phosphate trapping.:" The utilisation of glucose as an energy substrate requires more phosphate than that of fat (the major energy substrate during starvation.) If inadequate phosphate is provided. clinically significant hypophosphataemia, not; with impairment of central nervous system. cardiac. respiratory. skeletal muscle and leukocyte function (the refeeding syndrome) may develop.:" JII In the series of patients previously referred to. hypophosphataemia occurred in 30'X, and was life-threatening in 6% .lh Other factors that predispose to hypophosphatacmia include hyperglycaernia. insulin infusion. alcoholism. and previous treatment with thiazidcs or antacids. Serum phosphate concentrations should be measured daily in patients receiving parenteral nutrition. at least until their requirements are known. Thereafter. twice-weekly measurements are adequate.
SERUM CALCIUM
Provided that adequate calcium and magnesium are included in the feed. true hypocalcaemia (after correction for any hypoalburninacmia) is an uncommon complication of parenteral nutrition. Hypercalcaemia. on the other hand. is well recognised.P The cause appears to be increased bone resorption. Immobilisation may be a contributory factor but hypercalcaemia can occur in mobile patients being fed parenterally. Cases of hypercalcaemia associated with metabolic bone disease have been reported in patients on long-term parenteral nutrition who have responded to a reduction in or cessation of vitamin D intake .. '1 This has led to the suggestion that vitamin D metabolism may be abnormal in catients receiving total parenteral nutrition.' 2 but why it should be is not clear and several other possible causes of the bone disease have been suggested. including aluminium toxicity.F: .U Hypercalcaemia is anyway a fairly common metabolic disorder. and other causes should always be considered in a patient who develops hypercalcaemia during parenteral nutrition. Hypercalcaemia may occasionally be so severe as to precipitate pancreatitis..'4 Twiceweekly measurement of serum calcium concentration is adequate. except in patients who have previously been hypercalcaemic and patients with pancreatitis in whom hypercalcaemia might exacerbate the condition.
SERUM MAGNESIUM
Diarrhoea. intestinal fistulae and alcoholism are well-known causes of hypomagnesaemia. In a series of 26 consecutive patients treated with parenteral nutrition. all of whom received magnesium in supposedly normal amounts. J() had abnormally low serum magnesium concentrations at some time. Four patients were symptomatic hut responded to the provision of additional magnesium .: l ' Most of these patients had malignant disease. In addition to its direct effects. magnesium deficiency can cause hypokalacmia and hypocalcaemia which arc resistant to supplementation. Hypcrmagnesaemia is usually seen only in patients with renal impairment. In assessing the amount of magnesium to give it should be remembered that some amino acid solutions contain this element. Serum magnesium concentrations should be measured routinely once a week in patients on parenteral nutrition. and more frequently in those at risk of hypo-or hypermagnesaemia.
SERUM ZINC
Deficiency of zinc is a well-recognised complication of parenteral nutrition .''h .\7 Its manifestations include severe dermatitis. poor wound healing and defective cell-mediated immunity.: 'x Zinc deficiency may also impede the attainment of a postive nitrogen balance.:\<) Serum zinc concentration is a poor guide to tissue levels. hut in view of the consequences of zinc deficiency. a low serum concentration should be taken as an indication to provide additional zinc in the feeds. We recommend that the serum zinc concentration is measured at least every 2 weeks. especially in patients losing excessive quantities of fluid from the gastrointestinal tract and who are at particular risk of developing zinc deficiency.
OTHER TRACE EI.EMENTS
Patients receiving parenteral nutnnon are at risk of developing deficiencies of trace elements." for example copper .41 leading to anaemia and leukopenia; selenium." leading to cardiomyopathy; chromiurn;" leading to glucose intolerance. and molybdenum." possibly leading to amino acid intolerance. The serum concentration of these elements may not be a reliable guide to the body's requirements and few laboratories are in a position to measure them. Trace elements are usually added to parenteral feeds on ,111 empirical basis but the possibility of trace element deficiency should always be horne in mind. particularly in patients being given parenteral nutrition in the long term.
Patients being fed intravenously frequently develop biochemical abnormalities suggesting liver damage.:"~7 Biopsy studies have shown the presence of fatty infiltration and intrahepatic cholesrasis.:" and the biochemical changes reflect this with an increase in the serum activities of y-glutamyltranspeptidase and alkaline phosphatase. Aminotransferases are also commonly elevated hut this may occur in the absence of cholestasis, JS The frequency of raised serum hiliruhin concentrations varies considerably between different series.""~x.~\) but clinical jaundice is rare. In adults. this is a benign condition; the changes are reversihle on stopping parenteral nutrition and permanent liver damage does not occur."" J'} Severe.
progressive jaundice and hepatic fihrosis have. however. been reported in premature infants receiving parenteral nutrition. '\11
The pathogenesis of these abnormalities is uncertain. It is probable that the fatty infiltration and cholestasis are partly a result of the provisions of energy substrates in excess of requirements. particularly dextrose which is converted to fat in the liver. hut also lipid emulsions. '\I '\. 1 The clinical significance of this nutntionassociated cholestasis lies in the difficulty of distinguishing it from other causes of similar biochemical changes. e.g. sepsis and metastatic carcinoma, etc. If the diagnosis is in doubt, resolution of the abnormalities following a reduction of energy intake will indicate the cause retrospectively. However. our own experience. and that of others."? suggests that it is rarely necessary to do this. We recommend that serum hilirubin . alkaline phosphatase. aspartate aminotransferase and y-glutamyltranspeptidase be measured only once a week in patients being given parenteral nutrition. unless clinical considerations dictate a greater frequency.
NITROGEN "A LANCE
One of the aims of nutritional support is to promote a positive nitrogen balance. Two hiochemical techniques are available for its measurement. the measurement of the concentrations of certain serum proteins and the measurement of urinary nitrogen excretion.
Although the attainment of positive nitrogen balance is associated with increased synthesis of serum proteins. there arc. as discussed previously. many other factors which influence their concentration. The half-life of albumin is too long (21 days) for it to be of practical use except in long-term parenteral nutritional support. The disadvantages of using transferrin, which has a half-life of 8 days. for this purpose have also been referred to. The serum concentrations of both retinol-binding protein (halflife 12 h) and prealbumin (half-life 2 days) increase rapidly on refeeding starved subjects." prealburnin being the more sensitive. Measurements of these proteins are valuable in research. for example in the evaluation of different nutritional regimens. They may also be helpful in the management of patients with very high nitrogen and energy requirements but they are not necessary for the management of most patients requiring nutritional support.
Measurement of urinary nitrogen excretion hy the Kjeldahl technique is not practical for routine purposes. However. since urea is the major nitrogenous component of the urine. and urea and nitrogen excretion correlate well, II even in patients with liver disease;" urinary urea excretion can he used as a hasis for estimating nitrogen balance. 500 mmol of urea corresponds to 14 g of nitrogen and it is usual to add 2 g to this figure to allow for additional nitrogen losses. This simple formula is not valid in patients whose serum urea is changing. in those with infected urine or in patients with excessive non-renal nitrogen losses (e.g. from hurnt surfaces. through fistulae or in faeces). It is. however. satisfactory for use in the majority of patients and 24-h urine collections should be made twice a week for this purpose.
OTHER MEASUREMENTS
When lipid is being used as an energy source. it is advisable to inspect all serum samples to see if they are lipaemic. If they are not. or are only slightly opalescent. it may be inferred that lipid is being cleared adequately. If the serum is turbid. it may be necessary to reduce the rate of administration of lipid. It is sometimes recommended that lipid be infused for only part of the 24-h period. to prevent possible physical contamination of the membranes of ion-selective electrodes and interference in Coulter counters. In our experience, this is not a problem provided that the serum is not turbid. Spurious hyponatraernia, due to replacement of plasma water by lipid particles. is only seen with gross lipaemia.
Measurements of serum osmolality are unnecessary in patients receiving parenteral nutrition. It provides no more information than the osmolarity calculated from sodium. potassium, urea and glucose concentrations. Hyper-ammonaemia is an occasional complication of parenteral nutrition in infants,~~but is rare in adults.
Long-term parenteral nUlrilion
Most courses of parenteral nutrition last for less than a month. We have pointed out that biochemical monitoring will tend to be more intensive during the first week of parenteral feeding and that most tests can safely be performed less frequently once a patient's metabolic and nutritional requirements have become stable. Occasionally. patients need feeding for periods of months or even years. and home parenteral nutrition is now a wellestablished technique. which may allow patients to resume their work and other responsibilities.~I, Biochemical monitoring need then only be performed at 4-to 6-weekly intervals; it is particularly important to be alert for deficiencies of trace elements in such patients.
Involvemenl of clinical biochemisls and chemical palhologislS in parenteral nUlrilion
Laboratory results are of great importance in the management of patients requiring parenteral nutrition, but the role of the laboratory should not be limited to the analysis of samples and the reporting of results.~7 Protocols for investigation and monitoring of patients should be agreed between the laboratory and the clinical staff. It is now common practice for patients requiring parenteral nutrition to be referred to specialist multi-disciplinary teams which may include a surgeon. gastroenterologist, nursing sister, pharmacist and dietician.~x '" A chemical pathologist or clinical biochemist should also be a member of such a team. The results of analyses need to be available to the team rapidly. so that the composition of the feed can be changed rapidly in response to any metabolic imbalance. The close co-operation of the laboratory is essential for this. Furthermore, chemical pathologists may have particular expertise in managing patients with the metabolic conditions that can complicate parenteral nutrition.
